Answer
Population pharmacokinetic analysis confirms that concomitant leukotriene antagonists or systemic corticosteroids do not affect reslizumab pharmacokinetics, although no formal clinical interaction studies have been performed.
Sources for this answer
- Cinqaero (reslizumab) 10 mg/mL concentrate for solution for infusionTeva Pharmaceuticals Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 8Document updated
Sources checked